A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/1999
11/17/1999	CN1235015A Use of nanodispersions in cosmetic end formulations
11/17/1999	CN1046511C Benzoylecgonine, ecgonine and ecgonidine derivatives
11/16/1999	US5986131 RXR selective ligands
11/16/1999	US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999	US5985928 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
11/16/1999	US5985922 Amino acid derivatives and active oxygen-resisting agent
11/16/1999	US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999	US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999	US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999	US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999	US5985849 Phosphate compounds and their use as medicaments
11/16/1999	US5985839 Treating cancer, psoriasis, acne
11/16/1999	US5985610 Gene expression in host cell of conformational epitopes
11/16/1999	US5985292 Active phospholipids as a vector for active molecules
11/11/1999	WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999	WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999	WO1999057148A1 Melanocortin 1 receptor selective compounds
11/11/1999	WO1999057118A1 Novel n-oxides
11/11/1999	WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999	WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999	WO1999056746A1 Hydroxyomeprazole compositions and uses
11/11/1999	WO1999056740A1 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
11/11/1999	WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999	WO1999056719A1 Skin care agents containing combinations of active agents consisting of vitamin a derivatives and ubi- or plastoquinones
11/11/1999	WO1999056713A1 Plant extracts useful for fighting against hair loss and preparation
11/11/1999	WO1999047677A3 Polypeptides homologous to vegf and bmp1
11/11/1999	WO1999047563A3 Ribonucleotide polypeptides containing metal
11/11/1999	WO1999044582A3 Nontoxic vernix compositions and method of producing
11/11/1999	WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999	WO1999040073A3 Tryptase inhibitors
11/11/1999	DE19820392A1 Wirkstoffkombinationen enthaltende Hautpflegemittel Drug combinations containing skin care products
11/11/1999	CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999	CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999	CA2330738A1 Novel n-oxides of benzonaphthyridines
11/11/1999	CA2330049A1 Hydroxyomeprazole compositions and uses
11/11/1999	CA2329758A1 Plant extracts useful for fighting against hair loss and preparation
11/11/1999	CA2327550A1 Melanocortin 1 receptor selective compounds
11/11/1999	CA2326402A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/10/1999	EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999	EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999	EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999	EP0954322A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition
11/10/1999	EP0954321A1 Synergistic gold-containing compositions
11/10/1999	EP0954302A1 Therapeutic methods and compositions involving isoflavones
11/10/1999	EP0954280A1 Use of an extract of terminalia catappa
11/10/1999	EP0954279A2 Pharmaceutical, cosmetic composition with base of microbial culture mixed with an essential oil and an acid
11/10/1999	EP0954278A1 Pharmaceutical compositions containing kukui nut oil
11/10/1999	CN1234799A 1,4-disubstituted piperazines
11/10/1999	CN1234735A Method for treating skin pigmentation
11/10/1999	CN1234396A Process for alkylation of hindered sulfamide
11/10/1999	CN1234239A Sprayed powder for treating macerative erosive beriberi
11/10/1999	CN1234227A Face-beauty composition containing biological repair factor and its application
11/10/1999	CN1046274C Isoxazoline compounds as antinflammatory agents
11/09/1999	US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999	US5981776 Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
11/09/1999	US5981731 Anticarcinogenic/antitumor/antiproliferative agents and diagnostic agents targeted against gene which codes for a protein kinase involved in signal transduction
11/09/1999	US5981605 Containing more than 90% of a drying and/or protein coagulating, short-chained alcohol or alcohol mixture, primarily ethanol, and gelling agent; good skin-adhesive properties, matrix formation, forms a protective coating
11/09/1999	US5981588 Administering to a patient an omega 9-unsaturated fatty acid having at least two double bonds in an amount effective for preventing or alleviating medical symptoms caused by delayed allergy reaction
11/09/1999	US5981579 Use of nitrovasodilators for treatment of disease or stress conditions in a non-human mammal
11/09/1999	US5981574 Phenanthrofuran derivatives
11/09/1999	US5981543 Method of treating androgenic alopecia with 5α-reductase inhibitors
11/09/1999	US5981513 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/09/1999	US5981497 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
11/09/1999	US5981491 Peptides; metalloenzymes; tumor necrosis factor
11/09/1999	US5981490 Peptidyl compounds
11/09/1999	US5981478 Integrin-binding peptides
11/09/1999	US5981261 Pure culture for production of bacteriocin, for preparing foodstuffs such as sausages and cosmetics
11/09/1999	US5981256 Recombinant stratum corneum chymotryptic enzyme (SCCE)
11/09/1999	US5980933 Transdermal formulation of xanomeline
11/09/1999	US5980925 A washing solution comprising an anchoring agent for improving the efficacy of a polar microbiocide agent on the skin; hand washes, wound cleansers, body washes, mouthwashes, surgical scrubs
11/09/1999	US5980918 A wound and burns healing mixture in creams and gels
11/09/1999	US5980916 Use of laminarin and oligosaccharides derived therefrom in cosmetics and for preparing a skin treatment drug
11/09/1999	US5980904 A cosmetic composition for topical use for inhibiting melanin synthesis
11/09/1999	US5980865 Administering to the patient of a pharmaceutical composition containing about 0.005 to about 1.0 mg of ultra-low molecular weight heparins
11/09/1999	CA2157750C Photocleavable sequestering agents and compositions thereof
11/04/1999	WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999	WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999	WO1999055699A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders
11/04/1999	WO1999055678A1 Quinoline derivatives
11/04/1999	WO1999055352A1 Skin whitening composition
11/04/1999	WO1999055349A1 Substance mixture for topical application comprising olive oil and honey
11/04/1999	WO1999055347A2 Treatment of papilloma virus infection using a mycobacterium
11/04/1999	WO1999055335A1 Substituted tricyclic pyrazole derivatives with protein kinase activity
11/04/1999	WO1999055330A1 Ccr-3 receptor antagonists
11/04/1999	WO1999055324A1 Ccr-3 receptor antagonists
11/04/1999	WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999	WO1999055308A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin
11/04/1999	WO1999055302A1 Composition and method for treatment of aging skin
11/04/1999	WO1999055301A1 Use of horseradish peroxidase in cosmetic or dermopharmaceutical compositions for preventing and/or repairing skin damage induced by oxygen radical forms
11/04/1999	WO1999055158A1 S-rabeprazole compositions and methods
11/04/1999	WO1999055157A1 R-rabeprazole compositions and methods
11/04/1999	WO1999045909A3 Use of nitrone compounds for the inhibition of angiogenesis
11/04/1999	WO1999038858A8 Benzo[b]pyran derivatives useful as external agents for the skin
11/04/1999	CA2330387A1 Treatment of papilloma virus infection using a mycobacterium
11/04/1999	CA2330324A1 S-rabeprazole compositions and methods
11/04/1999	CA2330139A1 R-rabeprazole compositions and methods
11/04/1999	CA2329913A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders
11/04/1999	CA2329821A1 Ccr-3 receptor antagonists
11/04/1999	CA2329777A1 Ccr-3 receptor antagonists
11/04/1999	CA2329301A1 Substance mixture for topical application comprising olive oil and honey

1 ... 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 ... 1065